CA2001673C - Compose pharmaceutique contenant du piroxicam - Google Patents
Compose pharmaceutique contenant du piroxicamInfo
- Publication number
- CA2001673C CA2001673C CA002001673A CA2001673A CA2001673C CA 2001673 C CA2001673 C CA 2001673C CA 002001673 A CA002001673 A CA 002001673A CA 2001673 A CA2001673 A CA 2001673A CA 2001673 C CA2001673 C CA 2001673C
- Authority
- CA
- Canada
- Prior art keywords
- mass
- parts
- pharmaceutical composition
- process according
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU5621/88 | 1988-10-28 | ||
| HU885621A HU200926B (en) | 1988-10-28 | 1988-10-28 | Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2001673A1 CA2001673A1 (fr) | 1990-04-28 |
| CA2001673C true CA2001673C (fr) | 1996-08-27 |
Family
ID=10970484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002001673A Expired - Fee Related CA2001673C (fr) | 1988-10-28 | 1989-10-27 | Compose pharmaceutique contenant du piroxicam |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPH02172918A (fr) |
| AT (1) | AT399277B (fr) |
| CA (1) | CA2001673C (fr) |
| DE (1) | DE3936112C2 (fr) |
| FR (1) | FR2638357B1 (fr) |
| GB (1) | GB2224207B (fr) |
| HU (1) | HU200926B (fr) |
| IL (1) | IL92138A (fr) |
| IT (1) | IT1239542B (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2642486B2 (ja) * | 1989-08-04 | 1997-08-20 | 田辺製薬株式会社 | 難溶性薬物の超微粒子化法 |
| JP2964195B2 (ja) * | 1992-04-28 | 1999-10-18 | エスエス製薬株式会社 | ピロキシカム錠及びその製造法 |
| DE19603402A1 (de) * | 1995-02-24 | 1996-08-29 | Basf Ag | Weichgelatinekapseln |
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| JP3797387B2 (ja) * | 1996-06-14 | 2006-07-19 | 協和醗酵工業株式会社 | 口腔内速崩壊錠 |
| AU763143B2 (en) * | 1998-04-08 | 2003-07-17 | Kyowa Hakko Kirin Co., Ltd. | Tablet manufacturing method and tablet |
| JP2000095674A (ja) | 1998-09-22 | 2000-04-04 | Sato Pharmaceutical Co Ltd | 口腔内崩壊時間短縮化錠剤の製造方法及び装置 |
| US9358214B2 (en) | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
| JP4633469B2 (ja) * | 2002-12-16 | 2011-02-16 | キッセイ薬品工業株式会社 | 経口固形医薬 |
| US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
| US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
| US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
| NZ589750A (en) | 2004-10-21 | 2012-07-27 | Aptalis Pharmatech Inc | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
| US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
| PT1920786E (pt) | 2005-07-25 | 2011-12-28 | Otsuka Pharma Co Ltd | Preparação oral para avaliar a capacidade metabólica da pirimidina |
| CN102958515A (zh) | 2009-12-02 | 2013-03-06 | 阿普塔利斯制药有限公司 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
| CA2882528A1 (fr) | 2012-08-20 | 2014-02-27 | Otsuka Pharmaceutical Co., Ltd. | Methode de mesure de l'aptitude a metaboliser les hydrates de carbone, et composition a utiliser dans ladite methode |
| KR20210014204A (ko) | 2013-03-15 | 2021-02-08 | 오츠카 세이야쿠 가부시키가이샤 | 지방산 연소에 의한 인슐린 저항성의 측정 방법, 및 그에 사용하는 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3591584A (en) * | 1968-08-27 | 1971-07-06 | Pfizer | Benzothiazine dioxides |
| GB1308533A (en) * | 1969-06-02 | 1973-02-21 | Pfizer | Benzothiazine dioxides as anti-thombotic agents |
| JPS55129221A (en) * | 1979-03-29 | 1980-10-06 | Kaken Pharmaceut Co Ltd | Preparation of oral preparation containing hardly soluble medicine |
| US4350689A (en) * | 1980-02-15 | 1982-09-21 | American Cyanamid Company | Combinations of agents which give enhanced anti-inflammatory activity |
| US4434164A (en) * | 1981-06-01 | 1984-02-28 | Pfizer Inc. | Crystalline benzothiazine dioxide salts |
| RO88420A (fr) * | 1983-04-25 | 1986-01-30 | Pfizer Inc,Us | Procede pour la preparation des sels basiques de pyroxycam deposes sur supports pharmaceutiques |
| DE3419128A1 (de) * | 1984-05-23 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | Dihydropyridinpraeparate und verfahren zu ihrer herstellung |
| CH663899A5 (fr) * | 1985-03-20 | 1988-01-29 | Nestle Sa | Procede pour la preparation d'une composition a base d'un principe actif de faible hydrosolubilite finement divise. |
| ES545221A0 (es) * | 1985-07-02 | 1986-01-01 | Ferrer Int | Procedimiento de obtencion de particulas de 4-hidroxi-2-me- til-n-2-piridil-2h-1,2-benzotiazina-3-carboxamida-1,1-dioxi-do(piroxicam) recubiertas |
-
1988
- 1988-10-28 HU HU885621A patent/HU200926B/hu unknown
-
1989
- 1989-10-19 JP JP1270514A patent/JPH02172918A/ja active Pending
- 1989-10-27 CA CA002001673A patent/CA2001673C/fr not_active Expired - Fee Related
- 1989-10-27 IT IT22164A patent/IT1239542B/it active IP Right Grant
- 1989-10-27 AT AT0247489A patent/AT399277B/de not_active IP Right Cessation
- 1989-10-27 IL IL9213889A patent/IL92138A/en not_active IP Right Cessation
- 1989-10-27 GB GB8924286A patent/GB2224207B/en not_active Expired - Lifetime
- 1989-10-27 FR FR8914117A patent/FR2638357B1/fr not_active Expired - Fee Related
- 1989-10-30 DE DE3936112A patent/DE3936112C2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IT8922164A1 (it) | 1991-04-27 |
| CA2001673A1 (fr) | 1990-04-28 |
| GB2224207B (en) | 1992-06-10 |
| GB2224207A (en) | 1990-05-02 |
| GB8924286D0 (en) | 1989-12-13 |
| FR2638357B1 (fr) | 1993-10-22 |
| IT1239542B (it) | 1993-11-05 |
| DE3936112C2 (de) | 1999-02-18 |
| HU200926B (en) | 1990-09-28 |
| IT8922164A0 (it) | 1989-10-27 |
| HUT51143A (en) | 1990-04-28 |
| AT399277B (de) | 1995-04-25 |
| JPH02172918A (ja) | 1990-07-04 |
| FR2638357A1 (fr) | 1990-05-04 |
| DE3936112A1 (de) | 1990-05-31 |
| ATA247489A (de) | 1994-09-15 |
| IL92138A (en) | 1994-08-26 |
| IL92138A0 (en) | 1990-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2001673C (fr) | Compose pharmaceutique contenant du piroxicam | |
| RU2181590C2 (ru) | Фармацевтические композиции, содержащие ирбесартан | |
| AU684522B2 (en) | Pharmaceutical thermal infusion process | |
| US5824344A (en) | Pharmaceutical thermal infusion granules | |
| JP4787446B2 (ja) | グリブリド組成物 | |
| CA2644905A1 (fr) | Compositions a base d'ezetimibe | |
| TWI415633B (zh) | Solid preparations containing enteric solid dispersions | |
| CZ300558B6 (cs) | Tabletová kompozice nesteroidního protizánetlivého léciva a zpusob její prípravy | |
| EP0365480B1 (fr) | Composition à disperser | |
| Bolhuis et al. | Evaluation of anhydrous α-lactose, a new excipient in direct compression | |
| GB2284760A (en) | Sustained release morphine compositions | |
| JPS5927820A (ja) | スロクチジルを含有する徐放性製品 | |
| WO1997033571A1 (fr) | Preparation d'ecadotril a microdispersion et liberation rapides | |
| US6365196B1 (en) | Controlled release solid dosage forms of lithium carbonate | |
| US5827537A (en) | Pharmaceutical thermal infusion process | |
| JP2002068983A (ja) | ８−クロロ−６，１１−ジヒドロ−１１−（４−ピペリジリデン）−５Ｈ−ベンゾ［５，６］シクロヘプタ［１，２−ｂ］ピリジンの経口用組成物 | |
| CA1165242A (fr) | Compose alcalin comprime et moule pouvant etre utilise dans les produits d'acide acetylsalicylique tamponnes | |
| SK279927B6 (sk) | Orálne pevné farmaceutické prípravky obsahujúce ge | |
| NO318575B1 (no) | Stabile sammensetninger som omfatter levosimendan og alginsyre | |
| JPH10226644A (ja) | 医薬組成物 | |
| EP4465973B1 (fr) | Composition pharmaceutique d'un inhibiteur de cyp11a1 | |
| JPH0532554A (ja) | 顆粒状カルシウム組成物及びそれからなる錠剤 | |
| BG99630A (en) | Pharmaceutical compositions containing gemfibrosyl | |
| HK1002384B (en) | Pharmaceutical compositions containing irbesartan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |